Covid-PSMID
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 6 pages.
Return to Philippine COVID-19 Living Recommendations.
Covid-PSMID
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 7 pages.
Return to Philippine COVID-19 Living Recommendations.
Covid-PSMID
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 14 pages.
Return to Philippine COVID-19 Living Recommendations.
Covid-PSMID
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 7 pages.
Return to Philippine COVID-19 Living Recommendations.
Covid-PSMID
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 8 pages.
Return to Philippine COVID-19 Living Recommendations.
Covid-PSMID
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 20 pages.
Return to Philippine COVID-19 Living Recommendations.
Covid-PSMID
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 13 pages.
Return to Philippine COVID-19 Living Recommendations.
Covid-PSMID
You may download the most recent Living Clinical Practice Guidelines COVID-19 document here.
Document date: May 22, 2023
Covid-PSMID
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 12 pages.
Return to Philippine COVID-19 Living Recommendations.
Covid-PSMID
Click the up/down buttons found in the upper left or bottom left corner of the document to navigate. This document has 18 pages.
Return to Philippine COVID-19 Living Recommendations.
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.